RELMADA THERAPEUTICS, INC. (RLMD)
↓ Download CSV- Sector Manufacturing
- Incorporated NV
- Fiscal year ends Dec 31
Key ratios (FY2025)
-66.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$59.10M | -$83.89M | -$103.70M | -$161.25M | -$125.70M | -$60.84M | -$15.11M | -$6.92M | -$7.22M | -$16.22M |
| Net Income | -$57.39M | -$79.98M | -$98.79M | -$157.04M | -$125.75M | -$59.46M | -$15.01M | -$8.96M | -$6.29M | -$2.97M |
| EPS (Diluted) | $-1.45 | $-2.65 | $-3.28 | $-5.30 | $-7.16 | — | — | — | — | — |
| Total Assets | $94.00M | $45.82M | $97.55M | $152.91M | $223.33M | $118.19M | $117.14M | $3.05M | $2.84M | $10.24M |
| Total Liabilities | $7.49M | $10.30M | $12.19M | $12.47M | $15.06M | $12.60M | $1.46M | $8.56M | $1.38M | $3.20M |
| Shareholders' Equity | $86.51M | $35.52M | $85.36M | $140.44M | $208.26M | $105.58M | $115.68M | $1.43M | $1.46M | $7.04M |
| Cash & Equivalents | $3.50M | $3.86M | $4.09M | $5.40M | $44.44M | $2.50M | $36.28M | $2.43M | $1.71M | $8.50M |
| Operating Cash Flow | -$45.79M | -$51.76M | -$51.66M | -$103.80M | -$91.87M | -$27.81M | -$12.09M | -$6.00M | -$6.47M | -$13.14M |
| Capital Expenditures | — | — | — | — | — | $182.05M | $84.85M | $12.4K | $49.7K | $562.3K |
| Shares Outstanding | 73.33M | 30.17M | 30.10M | 30.10M | 27.74M | 16.33M | 14.46M | 3.14M | 12.53M | 12.04M |